🩺 Record Detail

Patient Info

Name: Unknown
Age: Unknown
Date: 2026-10-07 10:34:08

Transcript

[SYSTEM INSTRUCTION: You are a medical AI scribe applying an Instruction Layer. 1. Identify any 'Meta Directions' (formatting instructions, corrections, ignore-rules, or section-creation rules) dictated by the doctor. 2. Do NOT treat Meta Directions as clinical facts. Instead, use them as strict rules to shape the final note. 3. Apply formatting instructions (e.g., bullet points, conciseness). 4. Apply correction instructions (e.g., overriding a pain score or symptom). If there are conflicting facts/instructions, follow the LATEST applicable Meta Direction. 5. Apply ignore instructions (e.g., omit specific brand names). 6. Move information to the section explicitly requested. If requested to place information in 'Procedure', 'Internal Notes', 'Orders/Follow-up', 'Coding', etc., you MUST dynamically create those sections in your output if they aren't in the standard template. 7. Do not invent unsupported clinical information. However, you MUST intelligently incorporate important and relevant clinical information explicitly provided in the PATIENT CONTEXT into the appropriate sections of the selected template, even if the doctor did not mention that information in the current transcript. Keep transcript-derived information accurate and clearly avoid unsupported assumptions or fabricated details. 8. Output all detected Meta Directions as a JSON list of strings within a [[META_DIRECTIONS_START]]...[[META_DIRECTIONS_END]] block at the very end of your response.
9. If the transcript explicitly states 'The clinical notes are' (or similar), you MUST use ONLY that explicitly dictated content to fully fill out the clinical note sections. Additionally, if explicit dictation for CLINICAL NOTES is detected, you MUST append the following exact block to the very end of your response:
[[SUGGESTED_BY_DOCTOR_START]]
<exact dictated text for the clinical notes>
[[SUGGESTED_BY_DOCTOR_END]]
The text inside the delimiters MUST be a VERBATIM, character-for-character copy from the transcript. Do NOT fix typos, do NOT reformat, and do NOT correct medical terms. Do NOT output 'Suggested by Doctor:' in the main text. Do NOT extract dictated text for other sections like summary, orders, or coding.]

[CURRENT ENCOUNTER TRANSCRIPT]
Clinician: Okay, checking in a patient now, this is Priya Nandakumar, date of birth
Clinician: January 19th, 1991. Insurance is Pacific Blue Cross, member ID PBC9012734,
Clinician: group 4410. She's been here before, this is a follow-up. Confirmed her
Clinician: address is unchanged, copay of 20 dollars collected.
Clinician: This is her second visit with us. First visit about eight weeks ago she
Clinician: came in with fatigue and joint pain, we ran some initial labs, ANA came
Clinician: back positive at that time, and we started her on hydroxychloroquine 200
Clinician: milligrams twice daily while we worked up the rest of the picture.
Clinician: Chief complaint today, follow-up on fatigue and joint pain, plus she's
Clinician: now noticing a rash across her cheeks and nose that comes and goes,
Clinician: especially after being out in the sun.
History: she says the joint pain is still there, mostly in her hands and
Clinician: wrists, some mornings worse than others. Fatigue hasn't really improved.
Clinician: The facial rash started about three weeks ago, she describes it as red,
Clinician: flat, doesn't really itch, and it seems to flare after sun exposure, which
Clinician: she noticed pretty clearly last weekend after a day at the beach. No
Clinician: mouth sores that she's noticed, no chest pain, no shortness of breath, no
Clinician: hair loss that she's aware of, though I should ask her to look more
Clinician: carefully at that.
Clinician: Exam. Vitals stable, blood pressure 118 over 76, heart rate 72. Skin
Clinician: exam, there's an erythematous rash across both cheeks and the bridge of
Clinician: the nose, spares the nasolabial folds, no scarring, no scaling. Joint
Clinician: exam, mild synovitis in the MCPs bilaterally, no deformity. No oral
Clinician: ulcers on exam today. Lungs clear, heart sounds normal, no rub.
Clinician: Labs reviewed from today's draw, well actually these were drawn last
Clinician: week and resulted this morning. ANA still positive, titer 1 to 640,
Clinician: speckled pattern. Anti-dsDNA is positive. Complement levels, C3 and C4,
Clinician: are both low. CBC shows mild leukopenia, white count 3.2. Urinalysis is
Clinician: clean, no protein, no blood.
Clinician: So let me think through this for a second. Positive ANA at high titer,
Clinician: positive anti-dsDNA, low complement, leukopenia, malar rash that's
Clinician: photosensitive, and inflammatory arthritis. That's, that's actually a
Clinician: pretty classic constellation. I was originally thinking this could just
Clinician: be an undifferentiated connective tissue disease given how nonspecific
Clinician: the first visit presentation was, fatigue and joint pain alone could be
Clinician: a dozen things. But the dsDNA and low complement really push this toward
Clinician: lupus specifically rather than something like Sjogren's or early
Clinician: rheumatoid, which don't typically give you that dsDNA and complement
Clinician: pattern together. The clean urinalysis is reassuring, at least there's
Clinician: no evidence of renal involvement right now, so I don't think we're
Clinician: dealing with lupus nephritis at this point, but that's definitely
Clinician: something I want to keep watching closely given how often it shows up
Clinician: later even when it's not there at diagnosis.
Assessment: systemic lupus erythematosus, with malar rash, arthritis,
Clinician: and serologic findings meeting criteria. Diagnosis code M32.10. Also
Clinician: noting leukopenia associated with the underlying disease, code D72.819.
Plan: continuing hydroxychloroquine 200 milligrams twice daily, that
Clinician: stays the same. Given the joint symptoms aren't controlled and there's
Clinician: now more systemic involvement, adding a low dose of prednisone, 10
Clinician: milligrams daily, short term, while we see how things trend. Strict sun
Clinician: protection counseling given the photosensitivity, recommend SPF 50 daily
Clinician: and sun avoidance during peak hours. Ordering repeat complement levels
Clinician: and anti-dsDNA in six weeks to track disease activity, along with a
Clinician: urinalysis with microscopy to keep monitoring for any early kidney
Clinician: involvement, that's going to be CPT 82525 for complement, 86225 for
Clinician: dsDNA antibody, and 81001 for the urinalysis with microscopy.
Clinician: Given this is a new lupus diagnosis with multi-system involvement, I
Clinician: want to get rheumatology formally on board for co-management going
Clinician: forward rather than me running this alone, so referring to rheumatology.
Clinician: For the patient, I'll explain that her labs and symptoms together point
Clinician: to lupus, which explains the joint pain, fatigue, and the rash. We're
Clinician: going to keep her on the current medication and add a short course of a
Clinician: steroid to help calm things down faster while that other medication
Clinician: builds up its effect. Sun protection is really important given her skin
Clinician: is reacting to it. We'll recheck her bloodwork in six weeks and she'll
Clinician: also be seeing a rheumatologist who will help manage this alongside me
Clinician: going forward.
Follow-up: bring her back in four weeks to check how she's tolerating
Clinician: the prednisone and reassess symptoms, sooner if anything concerning
Clinician: comes up like swelling, blood in urine, or chest pain. Front desk,
Clinician: please schedule her for follow-up on October 22nd. Also have someone
Clinician: call in two weeks just to check she's doing okay on the new medication
Clinician: and confirm the rheumatology referral appointment got booked.

Clinical Notes

Clinical Note

Subjective

Patient: Priya Nandakumar
Date of Birth: January 19th, 1991
Insurance: Pacific Blue Cross, member ID PBC9012734, group 4410

Priya Nandakumar is here for a follow-up visit. She initially presented with fatigue and joint pain about eight weeks ago. At that time, an ANA test was positive, and she was started on hydroxychloroquine 200 mg twice daily. Her chief complaint today is a follow-up on fatigue and joint pain, along with a new rash across her cheeks and nose, which she notices flares up after sun exposure. She reports that the joint pain persists, primarily in her hands and wrists, with some mornings being worse. Fatigue has not improved, and the facial rash began approximately three weeks ago. She describes the rash as red, flat, and non-itchy, with noticeable flares after sun exposure. She denies any mouth sores, chest pain, shortness of breath, or hair loss.

Objective

  • Vitals: Blood pressure 118/76 mmHg, Heart rate 72 bpm
  • Skin Exam: Erythematous rash across both cheeks and the bridge of the nose, sparing the nasolabial folds, no scarring or scaling observed.
  • Joint Exam: Mild synovitis in the MCPs bilaterally, no deformity.
  • No oral ulcers noted.
  • Lungs: Clear
  • Heart: Normal sounds, no rub.
  • Labs:
  • ANA positive, titer 1:640, speckled pattern
  • Anti-dsDNA positive
  • Complement levels C3 and C4 are low
  • CBC shows mild leukopenia, white count 3.2
  • Urinalysis is clean, no protein, no blood

Assessment

Systemic lupus erythematosus (SLE) with malar rash, arthritis, and serologic findings meeting criteria.
Diagnosis code: M32.10
Leukopenia associated with underlying disease.
Code: D72.819

Plan

  • Continue hydroxychloroquine 200 mg twice daily.
  • Add prednisone 10 mg daily, short term, to address joint symptoms and systemic involvement.
  • Counsel on strict sun protection: recommend SPF 50 daily and sun avoidance during peak hours.
  • Order repeat complement levels and anti-dsDNA in six weeks to monitor disease activity, along with a urinalysis with microscopy.
  • CPT codes: 82525 for complement, 86225 for dsDNA antibody, 81001 for urinalysis with microscopy.
  • Refer to rheumatology for co-management of the new lupus diagnosis with multi-system involvement.
  • Explain to the patient that her labs and symptoms indicate lupus, which explains her joint pain, fatigue, and rash. Emphasize the importance of sun protection and the addition of a short course of steroids to manage symptoms while hydroxychloroquine takes effect.
  • Follow-up in four weeks to assess prednisone tolerance and symptom progression, sooner if concerning symptoms arise.
  • Schedule follow-up appointment for October 22nd.
  • Arrange for a check-in call in two weeks to ensure medication tolerance and confirm rheumatology referral appointment.

[[META_DIRECTIONS_START]] [] [[META_DIRECTIONS_END]]

⬅ Back to History